Lefere et al. [22] showed that in NASH patients, the serum levels of Ang-2 increased directly and proportionally to the degree of inflammation, steatosis, swelling, and histological alteration, but not to the degree of fibrosis. The gene discussed is ANGPT2; the disease is metabolic dysfunction-associated steatohepatitis.